Oncology Research Studies - Lung

Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trial (ALCHEMIST)
ALCHEMIST

A Randomized, Phase III Study of Firstline Immunotherapy alone or in Combination with Chemotherapy in Induction / Maintenance or Postprogression in Advanced Nonsquamous Non-Small Cell Lung Cancer (NSCL) with Immunobiomarker SIGNature-driven Analysis.
EA5163/S1709 INSIGNA

LIMITED STAGE SMALL CELL LUNG CANCER (LS-SCLC): A PHASE III RANDOMIZED STUDY OF CHEMORADIATION VERSUS CHEMORADIATION PLUS ATEZOLIZUMAB
NRG-LU005